Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (5): 830-835    DOI: 10.12892/ejgo4021.2018
Case Report Previous articles | Next articles
Malignant transformation of caesarean scar endometriosis – presentation of three case reports and review of the literature
M. M. Żyła1, *(), M. Nowak1, T. Stetkiewicz1, M. Kostrzewa1, K. Księżakowska-Łakoma1, M. Wilczyński2, J. Danielska3, J. R. Wilczyński1
1 Department of Gynaecology and Oncological Gynaecology, Endoscopic and Oncologic Gynecology, Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland
2 Department of Surgical, Endoscopic and Oncologic Gynecology, Polish Mother’s Memorial Hospital Research Institute, Lodz, Poland
3 Department of Radiotherapy, Kopernik Oncologic Center, Lodz, Poland
Download:  PDF(1078KB)  ( 75 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Endometriosis (EN) is a very common disease affecting about 5-10% women in reproductive age. Besides ovaries and peritoneum, the abdominal wall is one of the most common localizations of endometrial implants. The occurrence of EN in these cases is associated with previous gynecological surgeries, especially with cesarean section, and is usually a benign condition. Malignant transformation of endometrial foci is very rare and in most cases it accompanies the ovarian EN. In this paper the authors present three cases of malignant transformation of cesarean scar EN: two into clear cell carcinoma, and one into peritoneal adenocarcinoma of Mullerian type (PAMT), which is the first described case of this type of EN-originated tumor.
Key words:  Endometriosis      Malignant transformation      Clear cell carcinoma     
Published:  10 October 2018     
*Corresponding Author(s):  M. M. Żyła     E-mail:  zyla3.monika@gmail.com

Cite this article: 

M. M. Żyła, M. Nowak, T. Stetkiewicz, M. Kostrzewa, K. Księżakowska-Łakoma, M. Wilczyński, J. Danielska, J. R. Wilczyński. Malignant transformation of caesarean scar endometriosis – presentation of three case reports and review of the literature. European Journal of Gynaecological Oncology, 2018, 39(5): 830-835.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo4021.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I5/830

[1] Mehmet Sait Bakır, Özer Birge, Ceyda Karadag, Selen Doğan, Hasan Aykut Tuncer, Tayup Simsek. Clinicopathological risk factors and survival analysis of ovarian cancer with synchronous endometrial cancer diagnosed after surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 499-505.
[2] Joseph J. Noh, Kyue-Hee Choi, Hyun-Soo Kim, Jeong-Won Lee. Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 174-178.
[3] Isao Otsuka. Clear cell carcinoma of the vagina followed by breast cancer in a patient without prenatal diethylstilbestrol exposure[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 638-639.
[4] Marcin Jedryka, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Fijalkowska, Rafal Matkowski. Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 375-379.
[5] Nozomu Yanaihara, Chihiro Sato, Masami Iwamoto, Kazu Ueda, Aikou Okamoto. Juvenile ovarian mature teratoma with malignant transformation diagnosed after laparoscopic surgery: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 465-467.
[6] S. Kim, K. J. Min, S. Lee, J. H. Hong, J. K. Lee, N. W. Lee, J. Y. Song. Clear cell carcinoma arising from abdominal wall endometriosis with lymph node metastasis - a rare case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1047-1050.
[7] J.-Y. Zhou, Y. Zou, L.-Q. Wang, S.-F. Fang, Y. Luo, Q.-H. Xie, F. Wang, O.-P. Huang. Novel CARD14 mutations in Chinese samples with ovarian endometriosis[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 765-769.
[8] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879-882.
[9] S. Kabukcuoglu, B. Hayit. Histopathologic features of advanced stage endometrial carcinoma[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 614-618.
[10] H. Katagiri, K. Nakayama, K. Nakamura, S. Razia, E. Sato, T. Ishibashi, M. Ishikawa, T. Minamoto, K. Iida, Y. Otsuki, S. Nakayama, N. Ishikawa, S. Kyo. Telomerase reverse transcriptase (TERT) promoter mutation is a rare event in ovarian clear cell carcinomas in the Japanese population[J]. European Journal of Gynaecological Oncology, 2019, 40(2): 220-223.
[11] Fanhui Meng, Chunhua Zheng, Yanyan Fan, Jiahui Zhang, Yan Fu. Clinical features and prognostic factors associated with malignant transformation of ovarian mature cystic teratoma[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 55-59.
[12] M. Terzic, S. Terzic, J. Dotlic, M. Dokic, M. Mitrovic, G. Bapayeva, N. Arsenovic, A.S. Lagana, M. Norton. Ovarian clear cell carcinoma associated with endometriosis: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2019, 40(1): 166-169.
[13] G. Giordano, A. Pezzuto, E.M. Silini. Ovarian metastasis from renal clear cell carcinoma: a case report with an intraoperative, immunohistochemical study, and a review of the literature[J]. European Journal of Gynaecological Oncology, 2018, 39(6): 1022-1027.
[14] Nan Song, Xin Yan, Yunong Gao. Recurrent ovarian clear cell carcinoma: a retrospective evaluation of the efficacy and prognostic factors[J]. European Journal of Gynaecological Oncology, 2018, 39(4): 569-574.
[15] A. Tampakis, E. C. Tampaki, P. Korkolopoulou, G. Rigas, K. Kontzoglou, E. Patsouris, G. Kouraklis. Glycogen-rich clear cell breast carcinoma in a luminal-Her2 molecular subtype: is it only a pathologic feature or is there a gap in therapy?[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 493-495.
No Suggested Reading articles found!